← Back to all trials
Enrolling By Invitation
NCT07611019
Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial
Conditions: Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)
Sex: All
Ages: 20 Years – N/A
Healthy volunteers: No
Phase: PHASE2, PHASE3
Enrollment: 400
Sponsor: National Taiwan University Hospital
Location: National Taiwan University Hospital Taipei
Summary
Post-operative atrial fibrillation after coronary artery bypass grafting (CABG)
Eligibility Criteria
Inclusion Criteria:
* Adults aged 20 years or older scheduled to undergo elective coronary artery bypass grafting (CABG), including either off-pump CABG or on-pump CABG.
* Ability to receive oral study medication before and after surgery.
* Provision of written informed consent before randomization.
Exclusion Criteria:
* History of atrial fibrillation or atrial flutter before surgery.
* Severe renal impairment (estimated glomerular filtration rate \
Source: ClinicalTrials.gov (NCT07611019). StuddyBuddy aggregates publicly available trial information.
